Stay informed with Mediware product news, events and webcast announcements. Click here to subscribe!

Mediware logo

For Blood Centers

For Blood Centers

From comprehensive donor recruiting products to robust lab management, leading blood centers leverage Mediware to ensure a safe and efficient blood supply.

For Blood Banks

For Blood Banks

As the leader in safe and effective transfusion management software, our suite of products reaches from the blood bank to the bedside to maximize efficiency and safety.

For Pharmacies

For Pharmacies

Hospitals of all sizes rely on these powerful medication management solutions to ensure safe and effective drug therapies, from the pharmacy to the patient’s bedside.

For Home Healthcare

For Home Healthcare

Providers of home infusion, HME and home health services leverage our software to ensure efficient operations and timely reimbursement across multiple facilities and lines of service.

For Performance Management

For Performance Management

InSight provides a blend of robust analytics, flexibility and ease of use to enable meaningful quality and improvement initiatives that span from hospital departments to the board room.

For Cellular Therapy

For Cellular Therapy

Cell therapy labs, cord blood banks and blood & marrow transplant programs rely on Transtem™ to streamline donor, collector, product and recipient information in one system.

Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

About Us

Every day thousands of healthcare managers and clinicians use Mediware® software solutions to manage and improve care across highly specialized acute, non-acute and community-based care settings. link

Product Support

At Mediware, we know our continued success depends entirely on our ability to satisfy your needs. That's why reliable support, comprehensive training and meaningful client communications and resources are a cornerstone of our business philosophy. We'll be here when you need us. link

Upcoming Events

In the Spotlight

Mediware Chief Financial Officer to Step Down in 2012

Mediware® Chief Financial Officer to Step Down in 2012

Michael Martens resigns at the Lenexa-based software company

LENEXA, KS Nov. 15, 2011 - Mediware Information Systems, Inc. (Nasdaq: MEDW) announced that Michael Martens will step down as chief financial officer of the company effective February 15, 2012. Mr. Martens leaves the Company to rejoin a former employer.

"I regret to announce Mike’s departure,” said Thomas Mann, Mediware’s president and chief executive officer. “He has been a tremendous asset and has done an exceptional job of positioning the Company for continued growth. We wish him the best as he moves on to his next challenge."

Mediware plans to conduct a national search for Mr. Martens’ replacement.

About Mediware

Mediware delivers interoperable best-of-breed software systems that integrate with electronic medical records to improve efficiencies and address safety concerns enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market. For more information about Mediware products and services, visit our web site at www.mediware.com.

###

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.